Super Micro Stock Is Dividing the Street. Why SMCI’s Great Run Is Under Threat. - Barron's
By:Barron's
Source:Barron's
Published:
Related News
Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
CNBC•Annika Kim Constantino
Danish pension fund to sell $100 million in Treasuries, citing 'poor' U.S. government finances - CNBC
AkademikerPension's move comes amid increasing tensions between Denmark and the U.S. over Greenland.
CNBC•Alex Harring
S&P 500 Sheds $750 Billion—Greenland’s Estimated Value—On Trump’s Threats, Economist Says - Forbes
Trump has escalated his campaign for U.S. control over the Danish territory.
Forbes•Ty Roush